Close Menu

A short story by the Weizmann Institute of Science's Peter Tsvetkov and Tel-Aviv University's Sharon Dekel posted at LabLit this week details a personified p53's visit with a "gene therapist." The transcription factor, it seems, is at odds with his roles in cancer and apoptosis. "When I was first discovered they accused me of being oncogenic, accused me of supporting cancer. It took them many years to understand that I am the good guy, that I'm a tumor suppressor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.